Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "SII"

36 News Found

Serum seeks DCGI approval for booster dose in India
News | December 02, 2021

Serum seeks DCGI approval for booster dose in India

The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India


Serum Life Sciences invests US $ 10 million in GreenLight Biosciences
Biotech | November 24, 2021

Serum Life Sciences invests US $ 10 million in GreenLight Biosciences

GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible


Novavax and Serum Institute receive EUA for Covovax
News | November 18, 2021

Novavax and Serum Institute receive EUA for Covovax

The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax


Novavax files emergency use listing with WHO for Covid-19 vaccine
Biotech | November 05, 2021

Novavax files emergency use listing with WHO for Covid-19 vaccine

All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO


Novavax and Serum Institute receive EUA for Covid-19 vaccine in Indonesia
Biotech | November 02, 2021

Novavax and Serum Institute receive EUA for Covid-19 vaccine in Indonesia

The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice


Novavax and Serum seek WHO approval for Covid-19 vaccine
News | September 24, 2021

Novavax and Serum seek WHO approval for Covid-19 vaccine

It is a recombinant nanoparticle protein-based vaccine


Serum Institute to supply polio vaccine for India’s universal immunisation plan
Drug Approval | September 15, 2021

Serum Institute to supply polio vaccine for India’s universal immunisation plan

The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry


DGCI green lights Biological E for Phase 2/3 trials of its Covid-19 vaccine candidate for children
Biotech | September 03, 2021

DGCI green lights Biological E for Phase 2/3 trials of its Covid-19 vaccine candidate for children

The trial will be conducted across 10 sites in India


SCHOTT and Serum Institute announce JV for pharma packaging
Packaging | August 17, 2021

SCHOTT and Serum Institute announce JV for pharma packaging

Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha